Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBMs Still Skeptical Of Part D; Is “Donut Hole” A Lifesaver?

Executive Summary

Potential Medicare prescription drug insurance plan providers should consider the "donut hole" to be a form of reinsurance that limits their exposure to risk, the Centers for Medicare & Medicaid Services suggests

You may also be interested in...



“Donut Hole” Waiver Planned By CMS; Merck Legacy Helps Medco In Part D

CMS is developing a waiver process that would provide up-front, capitated catastrophic coverage payments to Medicare Part D sponsors that design plans to fill in the "donut hole" coverage gap

“Donut Hole” Waiver Planned By CMS; Merck Legacy Helps Medco In Part D

CMS is developing a waiver process that would provide up-front, capitated catastrophic coverage payments to Medicare Part D sponsors that design plans to fill in the "donut hole" coverage gap

Medicare Rx Course Is Clearer Following Bush Victory

President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare

Related Content

Topics

UsernamePublicRestriction

Register

PS044437

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel